切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2025, Vol. 19 ›› Issue (06) : 720 -726. doi: 10.3877/cma.j.issn.1674-3253.2025.06.006

临床研究

后腹腔镜上尿路手术中良性大体积标本体内分块取出技术的应用研究
宋小飞, 巫嘉文, 孙阳()   
  1. 201199 上海,复旦大学附属闵行医院泌尿外科
  • 收稿日期:2025-06-30 出版日期:2025-12-01
  • 通信作者: 孙阳

Application of in-vivo segmentation and minimally invasive extraction of benign large specimens in retroperitoneoscopic upper urinary tract surgery

Xiaofei Song, Jiawen Wu, Yang Sun()   

  1. Department of Urology, Minhang Hospital Affiliated to Fudan University, Shanghai 201199, China
  • Received:2025-06-30 Published:2025-12-01
  • Corresponding author: Yang Sun
引用本文:

宋小飞, 巫嘉文, 孙阳. 后腹腔镜上尿路手术中良性大体积标本体内分块取出技术的应用研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(06): 720-726.

Xiaofei Song, Jiawen Wu, Yang Sun. Application of in-vivo segmentation and minimally invasive extraction of benign large specimens in retroperitoneoscopic upper urinary tract surgery[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(06): 720-726.

目的

探讨在泌尿外科上尿路疾病的后腹腔镜手术中,将良性大体积标本先在体内进行分块处理,然后在不延长切口的情况下将标本从放置套管的微创切口取出的可行性。

方法

选取2023年1月至2024年12月期间收治的肾上腺良性病变、无功能肾(非肿瘤或结核导致)和肾错构瘤等需要行腹腔镜下病变切除手术的患者,按研究条件筛选共有15例患者纳入研究。手术选择背侧切口为标本取出通道,背侧皮肤切开后使用Hasson技术建立腹膜后腔并放置套管。按常规手术流程完成对肾上腺、肾错构瘤和无功能肾的病变组织的切除。在标本取出环节,先将标本置入"微创外科专用切除组织取出器"(简称微创标本袋),在标本袋内对标本进行分块处理。对分块后的标本,在不延长切口的情况下按标本质地的不同采用不同的取出策略。并对标本的取出时间进行对比分析。

结果

所有病例在未延长切口的情况下,均顺利通过腹腔镜微创切口完成了标本的取出,标本微创取出率100%。按标本的取出时间排序为:肾错构瘤[9.52(8.35~10.69)min]、肾上腺髓样脂肪瘤[9.78(8.92~10.91)min]、肾上腺腺瘤[15.12(12.15~17.52)min]、肾上腺多发结节样增生[15.27(14.95~15.59)min]和无功能肾[23.31(21.87~24.57)min]。术后随访9~12个月,所有病例中无切口出血、感染和切口疝的发生。标本的取出时间一方面和标本的体积有关,另一方面和标本的质地有关。肾错构瘤和肾上腺髓样脂肪瘤的标本取出耗时最短,肾上腺腺瘤和肾上腺结节样增生标本的取出耗时居中。无功能肾标本的取出耗时最长。

结论

对于上尿路的良性大体积标本,经过体内分块处理后,在无需延长切口的情况下可顺利通过腹腔镜的微创切口取出。该方法简单可行,方便临床开展。

Objective

To explore the feasibility of segmenting benign bulk specimens in vivo and then removing them from a minimally invasive incision without extending the incision during retroperitoneoscopic surgery for upper urinary tract diseases in Urology.

Methods

Patients with adrenal benign lesions, non-functional kidney (not caused by tumor or tuberculosis) and renal hamartoma requiring laparoscopic resection of the lesions were selected from January 2023 to December 2024, and a total of 15 patients were included in the study. The dorsal incision was selected as the sample extraction channel. After the dorsal skin incision, Hasson technique was used to establish the retroperitoneal cavity and place the cannula. The adrenal, renal hamartoma and nonfunctional renal lesions were removed according to the routine surgical procedures. In the process of specimen extraction, the specimen is first placed into the "minimally invasive surgery special excision tissue extraction device" (referred to as the bag), and the specimen is processed in sections in the bag. Different extraction strategies were adopted according to the texture of the specimens without extending the incision. The extraction time of specimens was compared and analyzed.

Results

In all cases, specimens were successfully extracted through laparoscopic minimally invasive incision without extending the incision. The success rate of specimen removal through minimally invasive incisions is 100%. Ranked by the time of specimen removal, they were renal hamartoma [9.52 (8.35-10.69) min], adrenal medullary lipoma [9.78 (8.92-10.91) min], adrenal adenoma [15.12 (12.15-17.52) min], multiple nodular hyperplasia of the adrenal gland [15.27 (14.95-15.59) min], and non-functional kidney [23.31 (21.87-24.57) min]. The postoperative follow-up period was 9 to 12 months. No incision bleeding, infection or incisional hernia occurred in all cases. The extraction time of the specimen is related to the volume of the specimen on the one hand, and the texture of the specimen on the other hand. The extraction time of adrenal medullary lipoma and renal hamartoma was the shortest, and the extraction time of adrenal adenoma and adrenal nodular hyperplasia was the middle. The extraction time of non-functioning kidney specimens is the longest.

Conclusions

Benign bulk specimens of the upper urinary tract can be successfully removed through a minimally invasive laparoscopic incision without the need to extend the incision after in vivo segmentation. This method is convenient and feasible and worthy of clinical promotion.

图1 后腹腔镜手术切口位置示意图注:a为背侧切口即标本取出通道,b为腹侧操作孔,c为镜头孔
图2 后腹腔镜术中利用巾钳夹闭背侧切口
图3 后腹腔镜手术中良性标本分块和取出注:a和b示后腹腔镜术中使用卵圆钳自背侧切口取出脂肪组织;c示术中将标本置入标本袋中进行分块处理;d示将分块后的标本自背侧微创切口取出
表1 后腹腔镜手术切除的标本信息及分块取出时间汇总[中位数(范围)]
图4 经微创切口取出标本(图a)与延长切口取出标本(图b)的术后切口对比
[1]
肖辉, 季金峰, 曾显奎, 等. 后腹腔镜技术在上尿路疾病中的临床应用[J]. 中华全科医学, 2013, 11(5): 710-712. DOI: 10.16766/j.cnki.issn.1674-4152.2013.05.075.
[2]
Elashry OM, Giusti G, Nadler RB, et al. Incisional hernia after laparoscopic nephrectomy with intact specimen removal: caveat emptor[J]. J Urol, 1997, 158(2): 363-369.
[3]
朱伟, 吴中华, 胡海, 等. 泌尿外科腹腔镜手术标本取出策略的研究进展[J]. 国际泌尿系统杂志, 2023(1): 184-187. DOI: 10.3760/cma.j.cn431460-20210316-00046.
[4]
张旭, 泌尿外科腹腔镜与机器人手术学(第2版)[M],北京:人民卫生出版社, 2015, 13-14.
[5]
Gaur DD, Agarwal DKPurohit KC. Retroperitoneal laparoscopic nephrectomy:initial case report[J]. J Urol, 1993, 149(1): 103 -105. DOI: 10.1016/s0022-5347(17)36012-3.
[6]
刘侃, 张融. 后腹腔镜肾根治性切除术中肾标本取出方法的探索[J]. 国际泌尿系统杂志, 2022, 42(1): 53-56. DOI: 10.3760/cma.j.cn431460-20201211-00013.
[7]
Janetschek G, Bagheri F, Abdelmaksoud A, et al. Ligation of the renal vein during laparoscopic nephrectomy: an effective and reliable method to replace vascular staplers[J]. J Urol, 2003, 170(4): 1295-1297. DOI: 10.1097/01.ju.0000081303.79650.91.
[8]
Wang K, Liu DF, Wang L, et al. Inguinal incision as a successful route to extract the kidney during laparoscopic retroperitoneal live-donor nephrectomy[J]. Exp Clin Transplant, 2013, 11(5): 396-399. DOI: 10.6002/ect.2012.0180.
[9]
梁毅姝, 江夏, 孙荣生, 等. 腹腔镜手术切除标本袋内扩张取出法[J]. 南京军医学院学报, 2003(2): 134.
[10]
Rijo E, Misrai V, Aho T, et al. Recommendations for safe and efficient morcellation after endoscopic enucleation of the prostate[J]. Urology, 2018, 121: 197. DOI: 10.1016/j.urology.2018.06.027.
[11]
Steiner RA, Wight E, Tadir Y, et al. Electrical cutting device for laparoscopic removal of tissue from the abdominal cavity[J]. Obstet Gynecol, 1993, 81(3): 471-474.
[12]
Parker WH. Indications for morcellation in gynecologic surgery[J]. Curr Opin Obstet Gynecol, 2018, 30(1): 75-80. DOI: 10.1097/GCO.0000000000000427.
[13]
Milad MP, Milad EA. Laparoscopic morcellator-related complications[J]. J Minim Invasive Gynecol, 2014, 21(3): 486-491. DOI: 10.1016/j.jmig.2013.12.003.
[14]
Bai DS, Chen P, Qian JJ, et al. Modified laparoscopic hepatectomy for hepatic hemangioma[J]. Surg Endosc, 2015, 29(11): 3414-3421. DOI: 10.1007/s00464-014-4048-y.
[15]
Zapardiel I, Boria F, Halaska MJ, et al. Laparoscopic power morcellation: techniques to avoid tumoral spread[J]. J Minim Invasive Gynecol, 2021, 28(8): 1442-1443. DOI: 10.1016/j.jmig.2020.09.012.
[16]
中国医师协会妇产科医师分会妇科肿瘤专业委员会(学组). 实施腹腔镜下子宫(肌瘤)分碎术的中国专家共识[J]. 中国实用妇科与产科杂志, 2020, 36(7): 626-632. DOI: 10.19538/j.fk2020070113.
[17]
Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy: initial case report[J]. J Urol, 1991, 146(2): 278-282. DOI: 10.1016/s0022-5347(17)37770-4.
[18]
User HM, Nadler RB. Novel technique of renal entrapment for morcellation[J]. J Urol, 2003, 169(6): 2287-2288. DOI: 10.1097/01.ju.0000062544.91372.90.
[19]
Landman J, Venkatesh R, Kibel A, et al. Modified renal morcellation for renal cell carcinoma: laboratory experience and early clinical application[J]. Urology, 2003, 62(4): 632-634;discussion635. DOI: 10.1016/s0090-4295(03)00680-0.
[20]
Lesani OA, Zhao LC, Han J, et al. Safety and efficacy of laparoscopic radical nephrectomy with manual specimen morcellation for stage cT1 renal-cell carcinoma[J]. J Endourol, 2008, 22(6): 1257-1259. DOI: 10.1089/end.2008.0171.
[21]
Wu SD, Lesani OA, Zhao LC, et al. A multi-institutional study on the safety and efficacy of specimen morcellation after laparoscopic radical nephrectomy for clinical stage T1 or T2 renal cell carcinoma[J]. J Endourol, 2009, 23(9): 1513-1518. DOI: 10.1089/end.2009.0387.
[22]
Camargo AH, Rubenstein JN, Ershoff BD, et al. The effect of kidney morcellation on operative time, incision complications, and postoperative analgesia after laparoscopic nephrectomy[J]. Int Braz J Urol, 2006, 32(3): 273-279;discussion 279-280. DOI: 10.1590/s1677-55382006000300003.
[23]
Bishoff JT. Laparoscopic radical nephrectomy: morcellate or leave intact? Definitely morcellate![J]. Rev Urol, 2002, 4(1): 34-37.
[24]
Gabr AH, Gdor Y, Strope SA, et al. Approach and specimen handling do not influence oncological perioperative and long-term outcomes after laparoscopic radical nephrectomy[J] J Urol.2009,182(3):874-880. DOI: 10.1016/j.juro.2009.05.034.
[25]
Asimakopoulos AD, Gaston R, Miano R, et al. Laparoscopic pretransplant nephrectomy with morcellation in autosomic-dominant polycystic kidney disease patients with end-stage renal disease[J]. Surg Endosc, 2015, 29(1): 236-244. DOI: 10.1007/s00464-014-3663-y.
[26]
Lee DS, Kim HY, Lee SJ. Retroperitoneoscopic nephrectomy for huge autosomal-dominant polycystic kidney disease using morcellator[J]. Int Braz J Urol, 2018, 44(3): 651-652. DOI: 10.1590/S1677-5538.IBJU.2017.0258.
[27]
Yang G, Xu Y, Wan SP, et al. Use of endoscopic tissue morcellator in removing retroperitoneal fat in retroperitoneoscopic radical nephrectomy[J]. BMC Surg, 2020, 20(1): 77. DOI: 10.1186/s12893-020-00740-9.
[28]
汤乘, 阳光, 徐勇, 等. 组织粉碎器在腹膜后腹腔镜肾癌根治术中的应用研究[J]. 腹腔镜外科杂志, 2021, 26(10): 784-788, 796. DOI: 10.13499/j.cnki.fqjwkzz.2021.10.784.
[29]
Gill IS, Schweizer D, Hobart MG, et al. Retroperitoneal laparoscopic radical nephrectomy: the Cleveland clinic experience[J]. J Urol, 2000, 163(6): 1665-1670. DOI: 10.1016/s0022-5347(05)67516-7.
[30]
程庆, 禹刚, 王国任, 等. 改良Foley切口——后腹腔镜上尿路手术大标本取出的创新入路[J]. 现代泌尿外科杂志, 2020, 25(10): 876-879. DOI: 10.3969/j.issn.1009-8291.2020.10.004.
[31]
辛黎明, 高同斌, 苏道政, 等. 免扩口法在后腹腔镜下重度积水无功能肾切除术中的临床应用分析[J]. 中国医学创新, 2021, 18(2): 1-5. DOI: 10.3969/j.issn.1674-4985.2021.02.001.
[1] 徐颖, 宋雨, 黄欣, 周易冬, 孙强, 林燕. 精准医学时代局部晚期乳腺癌的诊治热点[J/OL]. 中华乳腺病杂志(电子版), 2025, 19(03): 139-144.
[2] 王淑君, 鲁虹言, 杨林娜, 马春亭, 张博涵, 孙天骏, 申传安. 群组化即时通信管理在危重烧伤患者救治中的应用[J/OL]. 中华损伤与修复杂志(电子版), 2022, 17(06): 507-512.
[3] 闫甲, 刘双池, 王政宇. 胆囊癌肿瘤标志物的研究和应用进展[J/OL]. 中华普通外科学文献(电子版), 2023, 17(05): 391-394.
[4] 贾杰东, 张彬, 韩帅红, 王东文. 前列腺癌多参数磁共振成像影像组学研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(01): 80-83.
[5] 韩帅红, 贾杰东, 张彬, 王东文. 精准医疗需求下副肾动脉的CT解剖特征研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(05): 339-342.
[6] 向莹莹, 伯雪, 冯欢, 李军, 褚玲玲. 基于"互联网+"精准医疗服务的发展现状[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(01): 143-144.
[7] 王双兴, 吴永杰, 孟兵, 张宏涛, 刁美, 张辉. 微创切口联合腹腔镜同期治疗先天性心脏病合并心外畸形[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 244-249.
[8] 何菁, 赵佳晖. 左右侧腹膜后腹腔镜肾上腺切除手术结果比较[J/OL]. 中华腔镜外科杂志(电子版), 2023, 16(02): 79-84.
[9] 邓超, 陈超, 易波, 王五艺, 郭奇, 赵滨, 付川川, 芮元祎, 郑阳春. 结直肠癌标本经直肠拖出术中肿瘤和肠腔周径测量的应用[J/OL]. 中华腔镜外科杂志(电子版), 2022, 15(06): 336-340.
[10] 付正伟, 樊奇, 周小平, 郑康霞, 骆赞, 钟金昆, 张芝良, 肖嘉伍, 殷志豪, 熊德海. 新一代达芬奇机器人低位直肠前切除经自然腔道标本拖出术临床应用[J/OL]. 中华腔镜外科杂志(电子版), 2020, 13(02): 103-107.
[11] 张金梅, 杨远荣. 类器官的应用研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2019, 09(01): 50-53.
[12] 杨飖, 周主青, 鲁兵, 朱哲, 江期鑫, 纪昉, 傅传刚. 经自然腔道取标本手术在3D腹腔镜直肠癌超低位前切除术中的近期疗效分析[J/OL]. 中华结直肠疾病电子杂志, 2021, 10(05): 462-469.
[13] 苏生林, 马金兰, 于弘明, 杨晓军. 单细胞测序技术在脓毒症免疫研究中的应用进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 279-286.
[14] 石颖, 左祥荣, 曹权. 急性呼吸窘迫综合征的表型及内型研究进展[J/OL]. 中华重症医学电子杂志, 2020, 06(02): 215-222.
[15] 林健振, 潘杰, 周慷, 胡克, 赵林, 管梅, 霍力, 桑新亭, 赵海涛. 多学科诊疗模式用于肝胆恶性肿瘤的精准及免疫治疗的实践及思考[J/OL]. 中华消化病与影像杂志(电子版), 2019, 09(01): 1-4.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?